GR72769B - - Google Patents

Info

Publication number
GR72769B
GR72769B GR64497A GR810164497A GR72769B GR 72769 B GR72769 B GR 72769B GR 64497 A GR64497 A GR 64497A GR 810164497 A GR810164497 A GR 810164497A GR 72769 B GR72769 B GR 72769B
Authority
GR
Greece
Application number
GR64497A
Other languages
Greek (el)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GR72769B publication Critical patent/GR72769B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR64497A 1980-03-31 1981-03-26 GR72769B (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (1)

Publication Number Publication Date
GR72769B true GR72769B (tr) 1983-12-02

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
GR64497A GR72769B (tr) 1980-03-31 1981-03-26

Country Status (30)

Country Link
JP (1) JPS56152415A (tr)
KR (1) KR860000841B1 (tr)
AR (1) AR225500A1 (tr)
AT (1) AT370996B (tr)
AU (1) AU541056B2 (tr)
BE (1) BE888209A (tr)
CA (1) CA1162479A (tr)
CH (1) CH647481A5 (tr)
CS (1) CS246051B2 (tr)
DD (1) DD157762A5 (tr)
DE (1) DE3112272A1 (tr)
DK (1) DK158564C (tr)
ES (1) ES8206545A1 (tr)
FI (1) FI70670C (tr)
FR (1) FR2480605A1 (tr)
GB (1) GB2074028B (tr)
GR (1) GR72769B (tr)
HU (1) HU183379B (tr)
IE (1) IE51070B1 (tr)
IL (1) IL62517A (tr)
IT (1) IT1170838B (tr)
LU (1) LU83270A1 (tr)
NL (1) NL8101531A (tr)
NO (1) NO156675C (tr)
NZ (1) NZ196519A (tr)
PH (1) PH17152A (tr)
PT (1) PT72774B (tr)
SE (1) SE455045B (tr)
SU (1) SU1056893A3 (tr)
ZA (1) ZA812084B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
ES2208946T3 (es) * 1996-08-23 2004-06-16 Sequus Pharmaceuticals, Inc. Liposomas que contienen un compuesto de cisplatino.
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
ES2928931T3 (es) 2018-03-29 2022-11-23 Project Pharmaceutics Gmbh Formulación farmacéutica líquida

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
AU541056B2 (en) 1984-12-13
GB2074028B (en) 1983-09-21
IL62517A (en) 1984-01-31
DK158564C (da) 1990-11-05
DE3112272C2 (tr) 1990-09-27
IE810715L (en) 1981-09-30
IL62517A0 (en) 1981-05-20
DD157762A5 (de) 1982-12-08
ES500869A0 (es) 1982-08-16
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
NO156675B (no) 1987-07-27
KR860000841B1 (ko) 1986-07-09
DK158564B (da) 1990-06-11
LU83270A1 (fr) 1981-10-29
IT8148090A0 (it) 1981-03-24
NO811081L (no) 1981-10-01
PH17152A (en) 1984-06-13
FR2480605A1 (fr) 1981-10-23
PT72774B (en) 1982-11-16
NZ196519A (en) 1983-06-17
AT370996B (de) 1983-05-25
FI70670C (fi) 1986-10-06
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
FR2480605B1 (tr) 1984-05-11
CA1162479A (en) 1984-02-21
SU1056893A3 (ru) 1983-11-23
DE3112272A1 (de) 1982-04-29
IT1170838B (it) 1987-06-03
IE51070B1 (en) 1986-09-17
ES8206545A1 (es) 1982-08-16
AU6816681A (en) 1981-10-08
SE8101990L (sv) 1981-11-13
SE455045B (sv) 1988-06-20
CS246051B2 (en) 1986-10-16
PT72774A (en) 1981-04-01
KR830004849A (ko) 1983-07-20
DK144281A (da) 1981-10-01
NL8101531A (nl) 1981-10-16
HU183379B (en) 1984-04-28
ZA812084B (en) 1982-04-28
FI70670B (fi) 1986-06-26
ATA150481A (de) 1982-10-15
JPS6360008B2 (tr) 1988-11-22
AR225500A1 (es) 1982-03-31

Similar Documents

Publication Publication Date Title
FR2473093B1 (tr)
FR2473466B1 (tr)
FR2473227B1 (tr)
FR2475102B1 (tr)
FR2473725B1 (tr)
FR2473981B1 (tr)
DE3153254A1 (tr)
FR2474036B1 (tr)
FR2474047B1 (tr)
FR2474476B1 (tr)
CH655498B (tr)
FR2474808B1 (tr)
FR2474065B1 (tr)
FR2473926B1 (tr)
FR2473558B1 (tr)
FR2480605B1 (tr)
FR2473214B1 (tr)
FR2474710B2 (tr)
FR2474627B1 (tr)
FR2474867B1 (tr)
FR2473162B3 (tr)
FR2473586B1 (tr)
CH655542B (tr)
FR2472905B1 (tr)
FR2474174B1 (tr)